Immuneering (IMRX) Change in Accured Expenses (2020 - 2024)
Historic Change in Accured Expenses for Immuneering (IMRX) over the last 5 years, with Q4 2024 value amounting to $380304.0.
- Immuneering's Change in Accured Expenses fell 8045.92% to $380304.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$200831.0, marking a year-over-year decrease of 12781.64%. This contributed to the annual value of -$200831.0 for FY2024, which is 12781.64% down from last year.
- Immuneering's Change in Accured Expenses amounted to $380304.0 in Q4 2024, which was down 8045.92% from $835677.0 recorded in Q3 2024.
- Immuneering's 5-year Change in Accured Expenses high stood at $2.1 million for Q3 2022, and its period low was -$2.8 million during Q1 2024.
- Over the past 5 years, Immuneering's median Change in Accured Expenses value was $444093.5 (recorded in 2022), while the average stood at $238743.2.
- Its Change in Accured Expenses has fluctuated over the past 5 years, first crashed by 46533.01% in 2022, then skyrocketed by 688387.05% in 2024.
- Over the past 5 years, Immuneering's Change in Accured Expenses (Quarter) stood at -$257046.0 in 2020, then soared by 314.39% to $551080.0 in 2021, then crashed by 83.84% to $89032.0 in 2022, then soared by 2085.96% to $1.9 million in 2023, then plummeted by 80.46% to $380304.0 in 2024.
- Its last three reported values are $380304.0 in Q4 2024, $835677.0 for Q3 2024, and $1.3 million during Q2 2024.